Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

The rising price of insulin has become one of the most talked about issues across the pharma industry. Ben Hargreaves explains how Eli Lilly decided to cap its insulin price, why it has decided to ...

The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...